Drugs / tetwtCEA DNA
last change Aug 2016 re-read 2 minutes ago

tetwtCEA DNA

Vaccine

Developed for
colorectal cancer
Investigated by
Cyto Pulse Sciences, Inc. · Karolinska Institutet · Maria Liljefors · Swedish Institute for Infectious Disease Control

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01064375 Dec 2009 → Mar 2012 colorectal cancer Maria Liljefors Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as tetwtCEA DNA ClinicalTrials.gov intervention name — accepted as the source's own label NCT01064375
Modality Vaccine “Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer” NCT01064375